In Montana, 911 calls reveal impact of heat waves on rural seniors

The FDA on Thurs­day ap­proved Phath­om Phar­ma­ceu­ti­cals’ potas­si­um-com­pet­i­tive acid block­er Vo­quez­na (vono­prazan) to treat ero­sive gas­troe­sophageal re­flux dis­ease (GERD), of­fer­ing a new class of treat­ment

Despite the limitations of body mass index (BMI), the measure effectively screened children and adolescents for elevated adiposity, both as expressed by fat mass index